Robert A. Aspbury serves as the President of Certara Predictive Technologies at Certara Inc., a leading provider of decision-support tools and technologies for optimizing drug development and improving health outcomes. In his role, Aspbury oversees the development and implementation of predictive technologies that enhance the efficiency and effectiveness of drug discovery and development processes. His leadership is instrumental in driving Certara's mission to transform traditional drug development into a more predictive, data-driven science. Aspbury brings a wealth of experience to Certara, with a robust background in the life sciences and technology sectors. Prior to joining Certara, he held several senior leadership positions at prominent organizations where he spearheaded initiatives that significantly advanced the use of technology in healthcare. His expertise in integrating cutting-edge technology solutions with pharmaceutical research has been pivotal in his career. Aspbury's strategic vision and commitment to innovation have earned him recognition as a thought leader in the industry, and he continues to contribute to the advancement of predictive analytics in drug development. Under Aspbury's guidance, Certara Predictive Technologies has achieved notable milestones, including the development of advanced modeling and simulation tools that have been adopted by major pharmaceutical companies worldwide. His focus on fostering collaboration between technology experts and pharmaceutical scientists has led to the creation of solutions that address critical challenges in drug development. Aspbury's dedication to improving patient outcomes through technological innovation positions Certara as a key player in the evolving landscape of healthcare and pharmaceuticals.